Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Ranked #8 Nationally by U.S. News & World Report.
Through this multi-center international study organized by the Children’s Oncology Group, researchers will compare standard chemotherapy for acute myeloid leukemia (AML) to treatment in which the investigational drug CPX-351 is used. For patients with the FLT3 gene mutation, the drug gilteritinib also will be tested. AML is a cancer of the bone marrow. CPX-351, which is approved for adult use, has been shown to stay in bone marrow longer and poses less of a risk for heart problems than traditional chemotherapy drugs. Gilteritinib, which is also approved for treatment of adults, has been shown to block the effects of an abnormal FLT3 gene in older AML patients, but has not yet been proven in children.
Subject to certain exclusion criteria, this study is enrolling patients through age 21 who have been diagnosed with AML.
Males and Females: Up through 21 years of age
Through random selection, some participants will receive standard chemotherapy and others will receive the drug CPX-351 in place of certain traditional chemotherapy drugs during the first phase of treatment, which is called induction. Gilteritinib will be introduced for applicable participants during induction and continued for the second phase of chemotherapy, called intensification, which does not involve GPX-351. Depending on risk stratification, the intensification phase may have multiple stages or may include stem cell transplantation for certain participants.
Visits: The number varies based on participant response to therapy.
Duration: About 6 months in most cases.
Children’s Oncology Group (AAML1831)
National Cancer Institute
Study Description at the National Institutes of Health
Cancer and Blood Disorder Research
Leukemia Overview and Causes
Jean M. Tersak, MD
For more information about the study or enrollment, please contact the UPMC Children’s Hospital of Pittsburgh Hematology-Oncology research team, at:
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With MyCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Support the hospital by making a donation online, joining our Heroes in Healing monthly donor program, or visiting our site to learn about the other ways you can give back.